These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31969483)

  • 1. Gene therapy delivering a paraoxonase 1 variant offers long-term prophylactic protection against nerve agents in mice.
    Betapudi V; Goswami R; Silayeva L; Doctor DM; Chilukuri N
    Sci Transl Med; 2020 Jan; 12(527):. PubMed ID: 31969483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
    Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
    Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 to afford protection against G-type nerve agents.
    Mata DG; Sabnekar P; Watson CA; Rezk PE; Chilukuri N
    Chem Biol Interact; 2016 Nov; 259(Pt B):233-241. PubMed ID: 27083144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
    Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.
    Valiyaveettil M; Alamneh Y; Rezk P; Biggemann L; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
    Biochem Pharmacol; 2011 Mar; 81(6):800-9. PubMed ID: 21219877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase activity against nerve gases measured by capillary electrophoresis and characterization of human serum paraoxonase (PON1) polymorphism in the coding region (Q192R).
    Kanamori-Kataoka M; Seto Y
    Anal Biochem; 2009 Feb; 385(1):94-100. PubMed ID: 18952040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro and in vivo evaluation of the efficacy of recombinant human liver prolidase as a catalytic bioscavenger of chemical warfare nerve agents.
    Rezk PE; Zdenka P; Sabnekar P; Kajih T; Mata DG; Wrobel C; Cerasoli DM; Chilukuri N
    Drug Chem Toxicol; 2015 Jan; 38(1):37-43. PubMed ID: 24641262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines.
    Curtin BF; Seetharam KI; Dhoieam P; Gordon RK; Doctor BP; Nambiar MP
    J Cell Biochem; 2008 Apr; 103(5):1524-35. PubMed ID: 17879943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
    Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
    Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
    Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs.
    Valiyaveettil M; Alamneh Y; Rezk P; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
    Toxicol Lett; 2011 May; 202(3):203-8. PubMed ID: 21329748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity.
    Valiyaveettil M; Alamneh YA; Doctor BP; Nambiar MP
    Toxicol Lett; 2012 Apr; 210(1):87-94. PubMed ID: 22301377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection.
    Hodgins SM; Kasten SA; Harrison J; Otto TC; Oliver ZP; Rezk P; Reeves TE; Chilukuri N; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):177-80. PubMed ID: 23123254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Human Paraoxonase 1 the Saviour Against the Persistent Threat of Organophosphorus Nerve Agents?
    Iyengar ARS; Pande AH
    Protein Pept Lett; 2019; 26(7):471-478. PubMed ID: 30942142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
    Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated human paraoxonase1 gene transfer to provide protection against the toxicity of the organophosphorus pesticide toxicant diazoxon.
    Duysen EG; Parikh K; Aleti V; Manne V; Lockridge O; Chilukuri N
    Gene Ther; 2011 Mar; 18(3):250-7. PubMed ID: 20981111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An OPAA enzyme mutant with increased catalytic efficiency on the nerve agents sarin, soman, and GP.
    Bae SY; Myslinski JM; McMahon LR; Height JJ; Bigley AN; Raushel FM; Harvey SP
    Enzyme Microb Technol; 2018 May; 112():65-71. PubMed ID: 29499783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolved stereoselective hydrolases for broad-spectrum G-type nerve agent detoxification.
    Goldsmith M; Ashani Y; Simo Y; Ben-David M; Leader H; Silman I; Sussman JL; Tawfik DS
    Chem Biol; 2012 Apr; 19(4):456-66. PubMed ID: 22520752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
    Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
    Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.